PROXICOR FOR CARDIAC TISSUE REPAIR CMCV-120-404

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,foreign report with the FDA on 2020-02-04 for PROXICOR FOR CARDIAC TISSUE REPAIR CMCV-120-404 manufactured by Aziyo Biologics, Inc..

Event Text Entries

[177561445] Manufacturing review of the device history record for the reported lot shows that all units were quality released on 11/27/2019 having met all internal qc acceptance requirements. There were no non-conformances associated with the manufacturing lot during production and final packaging. The oem supplier reviewed the sub-lots associated with the reported lot and confirmed that "all devices met specification. " the instructions for use provided with the proxicor for cardiac tissue repair product (art-20700b), under the section 'potential complications', states in part: "the following complications are possible. If any of these conditions occur, a medical professional should evaluate if the removal of the proxicor is required: patch dehiscence or rupture. " it can be noted that the reported saline soak time prior to use was 10 minutes. The ifu recommends soak time of 1-2 minutes. The exact cause of the reported event cannot be conclusively determined.
Patient Sequence No: 1, Text Type: N, H10


[177561446] On (b)(6) 2019 a newborn female patient underwent surgery for a diagnosis of aortic arch hypoplasia and ivc. Aziyo proxicor for cardiac tissue repair (ctr) was used. Once the patient was sutured, hemodynamic deterioration occured. Arterial line (umbilical artery cannulation) checked; malfunction is ruled out. An ecography checked the position of the ctr patch. Since the hemodynamic compromise was maintained, the patient was reconnected to extracorporeal circulation. Once again exposing the operative field, the doctor visualized that the ctr patch presents what he described as a "dissection" of the same. Ctr removed and replaced with a baxter peri-guard pericardium patch. Patient subsequently taken to neonatal icu where, after a couple of hours, patient expired.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3005619880-2020-00001
MDR Report Key9664341
Report SourceDISTRIBUTOR,FOREIGN
Date Received2020-02-04
Date of Report2020-02-04
Date of Event2019-12-24
Date Mfgr Received2020-01-06
Device Manufacturer Date2019-11-27
Date Added to Maude2020-02-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. ANDREW GREEN
Manufacturer Street1100 OLD ELLIS ROAD STE 1200
Manufacturer CityROSWELL GA 30076
Manufacturer CountryUS
Manufacturer Postal30076
Manufacturer G1AZIYO BIOLOGICS, INC.
Manufacturer Street1100 OLD ELLIS ROAD STE 1200
Manufacturer CityROSWELL GA 30076
Manufacturer CountryUS
Manufacturer Postal Code30076
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePROXICOR FOR CARDIAC TISSUE REPAIR
Generic NamePROXICOR FOR CARDIAC TISSUE REPAIR
Product CodeDXZ
Date Received2020-02-04
Model NumberCMCV-120-404
Lot NumberM19M1538
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerAZIYO BIOLOGICS, INC.
Manufacturer Address1100 OLD ELLIS ROAD STE 1200 ROSWELL GA 30076 US 30076


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2020-02-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.